| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population … A Cassini, LD Högberg, D Plachouras, A Quattrocchi, A Hoxha, ... The Lancet infectious diseases 19 (1), 56-66, 2019 | 2838 | 2019 |
| International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009 VD Rosenthal, H Bijie, DG Maki, Y Mehta, A Apisarnthanarak, ... American journal of infection control 40 (5), 396-407, 2012 | 721 | 2012 |
| International nosocomial infection control consortium (INICC) report, data summary for 2003-2008, issued June 2009 VD Rosenthal, DG Maki, S Jamulitrat, EA Medeiros, SK Todi, DY Gomez, ... American journal of infection control 38 (2), 95-104. e2, 2010 | 652 | 2010 |
| International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module VD Rosenthal, DG Maki, Y Mehta, H Leblebicioglu, ZA Memish, ... American journal of infection control 42 (9), 942-956, 2014 | 408 | 2014 |
| Surveillance for control of antimicrobial resistance E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ... The Lancet Infectious Diseases 18 (3), e99-e106, 2018 | 304 | 2018 |
| Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. G Samonis, A Gikas, EJ Anaissie, G Vrenzos, S Maraki, Y Tselentis, ... Antimicrobial agents and chemotherapy 37 (1), 51-53, 1993 | 222 | 1993 |
| Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005–2010 VD Rosenthal, R Richtmann, S Singh, A Apisarnthanarak, A Kübler, ... Infection Control & Hospital Epidemiology 34 (6), 597-604, 2013 | 189 | 2013 |
| Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis M Serra-Burriel, M Keys, C Campillo-Artero, A Agodi, M Barchitta, A Gikas, ... PloS one 15 (1), e0227139, 2020 | 188 | 2020 |
| Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options S Karakonstantis, EI Kritsotakis, A Gikas Journal of Antimicrobial Chemotherapy, 2019 | 150 | 2019 |
| Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level A Gikas, J Pediaditis, JA Papadakis, J Starakis, S Levidiotou, P Nikolaides, ... Journal of hospital infection 50 (4), 269-275, 2002 | 133 | 2002 |
| Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut G Samonis, A Gikas, P Toloudis, S Maraki, G Vrentzos, Y Tselentis, ... European Journal of Clinical Microbiology and Infectious Diseases 13 (8 …, 1994 | 133 | 1994 |
| International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module VD Rosenthal, I Bat-Erdene, D Gupta, S Belkebir, P Rajhans, F Zand, ... American journal of infection control 48 (4), 423-432, 2020 | 131 | 2020 |
| Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a … EI Kritsotakis, C Tsioutis, M Roumbelaki, A Christidou, A Gikas Journal of antimicrobial chemotherapy 66 (6), 1383-1391, 2011 | 128 | 2011 |
| Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the … S Karakonstantis, EI Kritsotakis, A Gikas Infection 48 (6), 835-851, 2020 | 120 | 2020 |
| Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional hand hygiene approach over 13 years in 51 cities of 19 limited-resource countries … VD Rosenthal, M Pawar, H Leblebicioglu, JA Navoa-Ng, ... Infection Control & Hospital Epidemiology 34 (4), 415-423, 2013 | 114 | 2013 |
| Spread of blaVIM-1-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase gene EV Scoulica, IK Neonakis, AI Gikas, YJ Tselentis Diagnostic microbiology and infectious disease 48 (3), 167-172, 2004 | 111 | 2004 |
| Repeated multi-centre prevalence surveys of hospital-acquired infection in Greek hospitals A Gikas, I Pediaditis, M Roumbelaki, G Troulakis, J Romanos, Y Tselentis Journal of Hospital Infection 41 (1), 11-18, 1999 | 104 | 1999 |
| Surgical treatment of spinal brucellosis P Katonis, M Tzermiadianos, A Gikas, P Papagelopoulos, A Hadjipavlou Clinical Orthopaedics and Related Research® 444, 66-72, 2006 | 91 | 2006 |
| Newer macrolides as empiric treatment for acute Q fever infection A Gikas, DP Kofteridis, A Manios, J Pediaditis, Y Tselentis Antimicrobial agents and chemotherapy 45 (12), 3644-3646, 2001 | 88 | 2001 |
| Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries JA Otter, NT Mutters, E Tacconelli, A Gikas, AH Holmes Clinical Microbiology and Infection 21 (12), 1057-1066, 2015 | 84 | 2015 |
